Abstract:Introduction Previous studies suggested that estrogen receptor alpha (ERα) plays an important role in the chemoresistance of breast cancers. However, large random trials failed to demonstrate any benefit of the concurrent estrogen antagonist tamoxifen on the chemotherapy efficacy. Thus, in the present study, the importance of the role of ERα in the chemoresistance of breast cancer cells was investigated. Methods The ERα-transfected Bcap37 cells and natural ERα-positive T47D breast cancer cells were treated using chemotherapeutic agents with or without 17-beta estradiol (E2) pretreatment. Their viabilities were assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assays. The dead cell rates were determined using propidium iodide dye exclusion tests, and the expression levels of Bcl-2 and Bax were detected through Western blot analysis. The effects of E2 on the growth of breast cancer cells were also determined via cell growth curve and cell cycle analysis. Results ERα activation by E2 increased the sensitivity of natural ERα-positive T47D breast cancer cells to chemotherapeutic agents. However, the increase in ERα expression in ERα-negative Bcap37 breast cancer cells also significantly increased their resistance. These phenomena cannot be explained by asserting that ERα mediated the chemoresistance of breast cancer cells by regulating the expression of Bcl-2 and Bax. Our findings show that ERα activation upregulated the expression of Bcl-2 in natural ERα-positive T47D breast cancer cells, whereas ERα activation by E2 downregulated and upregulated the Bcl-2 and Bax expression levels, respectively, in ERα-transfected Bcap37 cells. This phenomenon was due to the influence of ERα on the growth of breast cancer cells. Specifically, ERα activation enhanced the growth of natural ERα-positive breast cancer cells and thus increased their sensitivity to chemotherapeutic agents. However, ERα activation also inhibited the growth of ERα-transfected Bcap37 cells and increased the resistance of cancer cells to chemotherapeutic agents. Chemoresistance of ERα-transfected Bcap37 cells was only due to the specific growth inhibition by E2, which is not applicable to common ERα-positive breast cancer cells. Conclusions Although ERα was associated with chemoresistance of breast cancers, ERα itself did not mediate this resistance process.

[In Vitro Study of the Effects of Estrogen Receptor Beta Expression on the Biological Behavior of a Human Breast Cancer Cell Line].

ER β exerts multiple stimulative effects on human breast carcinoma cells

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway.

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells

Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.

The expressing signification of estrogen receptorβ in breast cancer

Estrogen-independent Effects of ER-α36 in ER-negative Breast Cancer

ERβ1 inhibits the growth of breast cancer MDA-MB-231 cell by upregulating p21 expression

Effects of exogenous ER β expression on the cell growth properties of MCF-7 breast cancer cell line

The Expression of Estrogen Receptor Α, Β in Different Breast Tissues and Its Relation with Breast Cancer

Lentivirus Mediated Estrogen Receptor β Overexpression Inhibits Epithelial-Mesenchymal Transition Associated Gene Expression in Breast Cancer Cells

Stable Transfection of Estrogen Receptor-Alpha Suppresses Expression of Cyclooxygenase-2 and Vascular Endothelial Growth Factor-C in MDA-MB-231 Breast Cancer Cells.

Identification of A Novel Estrogen Receptor Beta 1 Binding Partner, Inhibitor of Differentiation-1, and Role of Er Beta 1 in Human Breast Cancer Cells

Effects of ERβ gene over-expression on proliferation and apoptosis of colonic cancer cells

Impact of ER520, a Candidate of Selective Estrogen Receptor Modulators, on in Vitro Cell Growth, Migration, Invasion, Angiogenesis and in Vivo Tumor Xenograft of Human Breast Cancer Cells

Estrogen receptor β1 induces apoptosis of MDA-MB-231 breast cancer cells by regulating the expression of Bax gene

Estrogen Receptor β1 Induces Apoptosis of Breast Cancer by Upregulating Expression of p53 Gene

Estrogen Receptor Β2 Negatively Regulates the Transactivation of Estrogen Receptor Α in Human Breast Cancer Cells

Effects Of Estrogen On Breast Cancer Development: Role Of Estrogen Receptor Independent Mechanisms

The Expression of ERβ Protein Correlates with Vascular Endothelial Growth Factor and Its Prognostic Significance in Human Breast Cancer